219 related articles for article (PubMed ID: 24957886)
21. Evaluating Serum Markers for Hormone Receptor-Negative Breast Cancer.
Schummer M; Thorpe J; Giraldez MD; Bergan L; Tewari M; Urban N
PLoS One; 2015; 10(11):e0142911. PubMed ID: 26565788
[TBL] [Abstract][Full Text] [Related]
22. A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with breast cancer.
Liu Y; Liao Y; Xiang L; Jiang K; Li S; Huangfu M; Sun S
Int J Clin Oncol; 2017 Apr; 22(2):291-296. PubMed ID: 27778118
[TBL] [Abstract][Full Text] [Related]
23. Identification of vitronectin as a novel serum marker for early breast cancer detection using a new proteomic approach.
Kadowaki M; Sangai T; Nagashima T; Sakakibara M; Yoshitomi H; Takano S; Sogawa K; Umemura H; Fushimi K; Nakatani Y; Nomura F; Miyazaki M
J Cancer Res Clin Oncol; 2011 Jul; 137(7):1105-15. PubMed ID: 21253761
[TBL] [Abstract][Full Text] [Related]
24. Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy.
Park HS; Park S; Cho J; Park JM; Kim SI; Park BW
J Surg Oncol; 2013 Mar; 107(4):388-92. PubMed ID: 23007901
[TBL] [Abstract][Full Text] [Related]
25. Microcalcifications associated with ductal carcinoma in situ: mammographic-pathologic correlation.
Holland R; Hendriks JH
Semin Diagn Pathol; 1994 Aug; 11(3):181-92. PubMed ID: 7831529
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic accuracy of core biopsy for ductal carcinoma in situ and its implications for surgical practice.
Dillon MF; Quinn CM; McDermott EW; O'Doherty A; O'Higgins N; Hill AD
J Clin Pathol; 2006 Jul; 59(7):740-3. PubMed ID: 16803949
[TBL] [Abstract][Full Text] [Related]
27. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
Sakorafas GH; Tsiotou AG
Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968
[TBL] [Abstract][Full Text] [Related]
28. Digital mammography screening: association between detection rate and nuclear grade of ductal carcinoma in situ.
Weigel S; Heindel W; Heidinger O; Berkemeyer S; Hense HW
Radiology; 2014 Apr; 271(1):38-44. PubMed ID: 24475843
[TBL] [Abstract][Full Text] [Related]
29. Sensitivity of mammography and ultrasonography on detecting abnormal findings of ductal carcinoma in situ.
Boonjunwetwatmd D; Chyutipraiwan U; Sampatanukul P; Chatamra K
J Med Assoc Thai; 2007 Mar; 90(3):539-45. PubMed ID: 17427533
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic accuracy of high-resolution MRI using a microscopy coil for patients with presumed DCIS following mammography screening.
Zhu J; Kurihara Y; Kanemaki Y; Ogata H; Fukuda M; Nakajima Y; Maeda I
J Magn Reson Imaging; 2007 Jan; 25(1):96-103. PubMed ID: 17154376
[TBL] [Abstract][Full Text] [Related]
31. MRI of the breast as part of the assessment in population-based mammography screening.
Bick U; Engelken F; Diederichs G; Dzyuballa R; Ortmann M; Fallenberg EM
Rofo; 2013 Sep; 185(9):849-56. PubMed ID: 23740312
[TBL] [Abstract][Full Text] [Related]
32. Breast carcinoma in situ in 167 women--incidence, mode of presentation, therapy and follow-up.
Ringberg A; Andersson I; Aspegren K; Linell F
Eur J Surg Oncol; 1991 Oct; 17(5):466-76. PubMed ID: 1657650
[TBL] [Abstract][Full Text] [Related]
33. Predictors of invasive breast cancer and lymph node involvement in ductal carcinoma in situ initially diagnosed by vacuum-assisted breast biopsy: experience of 733 cases.
Trentin C; Dominelli V; Maisonneuve P; Menna S; Bazolli B; Luini A; Cassano E
Breast; 2012 Oct; 21(5):635-40. PubMed ID: 22795363
[TBL] [Abstract][Full Text] [Related]
34. Ductal carcinoma in situ: is there a role for MRI?
Zuiani C; Francescutti GE; Londero V; Zunnui I; Bazzocchi M
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):89-95. PubMed ID: 12585661
[TBL] [Abstract][Full Text] [Related]
35. Improvement in DCIS detection rates by MRI over time in a high-risk breast screening study.
Warner E; Causer PA; Wong JW; Wright FC; Jong RA; Hill KA; Messner SJ; Yaffe MJ; Narod SA; Plewes DB
Breast J; 2011; 17(1):9-17. PubMed ID: 21251121
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer.
Buist DS; Abraham LA; Barlow WE; Krishnaraj A; Holdridge RC; Sickles EA; Carney PA; Kerlikowske K; Geller BM;
Breast Cancer Res Treat; 2010 Dec; 124(3):863-73. PubMed ID: 20700648
[TBL] [Abstract][Full Text] [Related]
37. Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases.
Yeung DK; Yang WT; Tse GM
Radiology; 2002 Oct; 225(1):190-7. PubMed ID: 12355004
[TBL] [Abstract][Full Text] [Related]
38. The frequency of presentation and clinico-pathological characteristics of symptomatic versus screen detected ductal carcinoma in situ of the breast.
Barnes NL; Dimopoulos N; Williams KE; Howe M; Bundred NJ
Eur J Surg Oncol; 2014 Mar; 40(3):249-54. PubMed ID: 24433818
[TBL] [Abstract][Full Text] [Related]
39. The Dana-Farber CISNET Model for Breast Cancer Screening Strategies: An Update.
Lee SJ; Li X; Huang H; Zelen M
Med Decis Making; 2018 Apr; 38(1_suppl):44S-53S. PubMed ID: 29554465
[TBL] [Abstract][Full Text] [Related]
40. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
Cilotti A; Iacconi C; Marini C; Moretti M; Mazzotta D; Traino C; Naccarato AG; Piagneri V; Giaconi C; Bevilacqua G; Bartolozzi C
Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
